Pancreatic Cancer Research

ResearcherVan Yüzüncü Yıl ÜniversitesiActive in the last 2 years

Mustafa Yıldırım

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-4479-8136; OpenAlex author ID A5047700570. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 2

  1. Efficacy of gemcitabine plus nab-paclitaxel in second-line treatment of metastatic pancreatic cancer. Co-author DOI 10.1038/s41598-025-96157-6↗
  2. Expression pattern and prognostic significance of claudin 1, 4 and 7 in pancreatic cancer. Last author DOI 10.7314/apjcp.2015.16.10.4387↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Nargız Majidova · 1 shared paper, 2025 · strength 0.16
  2. Melike Özçelik · 1 shared paper, 2025 · strength 0.16
  3. İlkay Gültürk · 1 shared paper, 2025 · strength 0.16
  4. Abdullah Sakin · 1 shared paper, 2025 · strength 0.16
  5. Yasin Sezgin · 1 shared paper, 2025 · strength 0.16
  6. Bilgin Demir · 1 shared paper, 2025 · strength 0.16
  7. Yakup Ergün · 1 shared paper, 2025 · strength 0.16
  8. Mustafa Yıldız · 1 shared paper, 2015 · strength 0.05
  9. Arsenal Sezgin Alikanoğlu · 1 shared paper, 2015 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.